The tumor microenvironment is an integral component in promoting tumor development. Cancerassociated fibroblasts (CAFs), which reside in the tumor stroma, produce Hepatocyte Growth Factor (HGF), an important trigger for invasive and metastatic tumor behavior. HGF contributes to a pro-tumorigenic environment by activating its cognate receptor, c-Met, on tumor cells. Tumor cells, in turn, secrete growth factors that upregulate HGF production in CAFs, thereby establishing a dynamic tumor-host signaling program. Using a spatiotemporal multispecies model of tumor growth, we investigate how the development and spread of a tumor is impacted by the initiation of a dynamic interaction between tumor-derived growth factors and CAF-derived HGF. We show that establishment of such an interaction results in increased tumor growth and morphological instability, the latter due in part to increased cell species heterogeneity at the tumor-host boundary. Invasive behavior is further increased if the tumor lowers responsiveness to paracrine pro-differentiation signals, which is a hallmark of neoplastic development. By modeling anti-HGF and anti-c-Met therapy, we show how disruption of the HGF/c-Met axis can reduce tumor invasiveness and growth, thereby providing theoretical evidence that targeting tumor-microenvironment interactions is a promising avenue for therapeutic development.
Introduction
The tumor microenvironment consists of vascular endothelial cells, pericytes, immune inflammatory cells, and cancer associated fibroblasts (CAFs), all which contribute to the hallmarks of cancer ( Hanahan and Coussens, 2012; Hanahan and Weinberg, 2011 ) . CAFs include both tissue-derived fibroblasts and recruited myofibroblasts, and promote tumor invasion and metastasis via secretion of growth factors and extracellular matrix (ECM) components ( Bhowmick et al., 2004; Kalluri and Zeisberg, 2006 ) . CAF-derived Hepatocyte Growth Factor, HGF, contributes to a pro-tumorigenic environment by activating its cognate receptor, c-Met. High HGF/cMet activity has been identified in a large number of cancers and is correlated with more severe tumor grade and poor patient survival ( Christensen et al., 2005; Matsumoto and Nakamura, 2006; Organ and Tsao, 2011 ) . The signaling cascades triggered by c-Met include ( Jordan et al., 2006 ) . CSCs are currently regarded as a highly dynamic population, whose behavior is determined by both genetic and environmental factors, and may be, instead of a specific cell type amenable to therapeutic targeting, a phenotype that a large population of cancer cells can achieve in the appropriate environmental conditions ( Kreso and Dick, 2014; Zeuner et al., 2014 ) .
Mathematical models of tumor growth now compose several classes, including continuous, discrete, and hybrid; single compartment and multi-compartment (see Byrne, 2010; Deisboeck et al., 2011; Lowengrub et al., 2010; Wang et al., 2015 , for comprehensive reviews of the aforementioned model types). Incorporation of the microenvironment into these models involves adding an extra layer of complexity to an underlying model structure. Angiogenesis, macrophage infiltration, and stromal-mechanical perturbations have all been modeled by one or more of the previous model classes ( Anderson et al., 2006; Eftimie et al., 2011; Eikenberry et al., 2009; Frieboes et al., 2013; Katira et al., 2013; Rejniak and McCawley, 2010; Welter and Rieger, 2013; Yan et al., 2017; 2016 ) . Many of these modeling studies also include simulation of drug action in the complex milieu of the microenvironment. For example, Eikenberry et al. (2009) developed a partial differential equation model to investigate how surgical resection of a primary melanoma, along with its associated immune cells, would impact the stability of local metastases by disrupting the immune suppression induced by the primary tumor-resident immune cells. The model incorporated tumor-immune interactions into a spatially explicit system that could elucidate how therapy would impact the complex interplay of primary and satellite tumor cells with the immune response.
Despite the prevalence of tumor and tumor-microenvironment models, based on our current knowledge, no tissue-level models of CAF-tumor interactions have been developed that specifically addresses the HGF/c-Met and tumor-derived growth-factor signaling pathway dynamics. Using, as a starting point, a spatiotemporal, multispecies model of tumor growth that accounts for feedback signaling between CSCs and non-CSCs ( Yan et al., 2017; 2016; Youssefpour et al., 2012 ) , we investigate how the development and spread of a tumor is impacted by a dynamic interaction between tumor-derived growth factors and CAF-derived HGF, and the physiological effect of therapies directed at reducing the strength of this feedback mechanism.
The mathematical model

Overview
A multispecies continuum model of tumor growth with lineage dynamics and feedback regulation was developed by Youssefpour et al. (2012) , who investigated two-stage lineages primarily in two dimensions and Yan et al. (2016) , who investigated three-stage lineages in three dimensions. One-way coupling of HGF to tumor dynamics was investigated by Yan et al. (2017) , where a non-monotonic effect of external HGF treatment on tumor shape was shown: a low dose increased morphological asymmetry, whereas a higher dose resulted in a larger, but more morphologically stable tumor. In this work, we extend the investigation of HGF-mediated tumor growth by developing a model that incorporates a dynamic, two-way coupling between the tumor and HGF-producing CAFs ( Fig. 1 ) . The tumor tissue is modeled to be composed of three cell types: stem, terminal, and dead. While many cell lineage models also include committed progenitor cells as an intermediate phenotype between stem and terminal cells, our model classifies both committed progenitor and cancer stem cells in the stem cell category. We do this in order to lower the parameter burden and to simplify the model. In future work, we will consider these two compartments separately. Stem cells renew with probability P 0 and divide with rate λ MSC . Terminal cells die at a rate λ ATC and dead cells are converted to water. P 0 is promoted by products of the c-Met signaling cascade (M) and HGF, and lowered by TGF β, which is produced by the terminal cells. c-Met production, in turn, is promoted by itself and HGF, and lowered by c-Met inhibitors (MI). HGF production by CAFs is promoted by SGF, which are produced by stem and terminal cells. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)
Stem cells have a probability of self-renewal, P 0 , and a division rate, λ MSC , that are dependent upon negative feedback from TGF β family members produced by terminal cells and positive feedback from products of the c-Met signaling cascade. Stem cell scatter and motility are also increased by c-Met (not shown in Fig. 1 ). Additionally, c-Met is inhibited by stem-cell produced c-Met inhibitors. Cancer-associated fibroblasts, CAFs, reside in the host tissue, and interact with the tumor by secreting HGF, which is stimulated by release of stroma-acting growth factors (SGF) by the stem and terminal cells. HGF, in turn, promotes production of c-Met products.
Terminal cells die at a rate λ ATC , and dead cells are eventually converted to water ( Fig. 1 ). 
Cell species conservation, HGF-induced cell spread, and cell velocity
Local area fractions of the cell species ( φ CSC, TC, DC ), host ( φ H ), and water ( φ W ) make up the dependent variables, which sum to 1.
Assuming that that the total solid and water fractions are constant allows us to determine the water component via solid component dynamics. A conservation equation of the form δφ * δt
is assumed for each cell type, where * denotes tumor cell species. A Helmholtz free energy of global adhesion is given by Wise et al. (2008) and Youssefpour et al. (2012) 
where is the domain occupied by the tumor and host, φ T = φ CSC + φ T C + φ DC is the total solid tumor area fraction, F ( φ T ) models energy from local adhesion, ε models longer range component interactions, and γ is a global measure of cell-cell adhesion (incorporating both local and longer-range contributions to adhesion). Generalized diffusion for tumor components is represented by −∇ · J * , where J * = −M b φ * ∇μ. For the host, we have J H = M b φ T ∇μ. Here, M b is mobility and μ is the chemical poten-
Since the first discovery of HGF as a scatter factor for epithelial cells, HGF has been shown to have a pro-migratory effect on cells in the contexts of development, wound healing, and cancer ( Birchmeier et al., 2003 ) . The pro-migratory effect is mediated by several pleiotropic effects of activated c-Met on cell physiology. The c-Met-activated Ras cascade has been shown to be critical for disassembly of adherens junctions between tumor cells ( Potempa and Ridley, 1998; Ueoka et al., 20 0 0 ) . Additionally, activated c-Met results in increased production of the proteolytic enzyme urokinasetype plasminogen activator (uPA) and its receptor (uPAR) ( Jeffers et al., 1996; Nishimura et al., 2003 ) . uPA catalyzes ECM degradation and remodeling, and is correlated with increased malignancy in several cancers ( Duffy, 2004; Sidenius and Blasi, 2003; Ulisse et al., 2009 ) . In MDCK cells, HGF-activated c-Met was found to further promote cell dispersal by enhancing cell-ECM interactions via modification of cellular transmembrane integrin protein activity ( Trusolino et al., 20 0 0 ) .
We model the effect of c-Met on cell spread by having it act on the local interaction energy, F ( φ T ), as follows. First, we model F as a double-well potential and represent it as a sum of its convex and concave parts, which model cell-cell repulsion (and attraction to ECM), and cell-cell attraction, respectively, with cell-cell adhesion arising from a balance between the two ( Wise et al., 2008 ) . We can model the effect of HGF as shifting this balance via its effect on c-Met. Accordingly, we introduce a weighting function g ( C M ) and modify F as follows,
where ˜ E > 0 is an energy scale and C M is the concentration of c- (6) , where δ 1 is the strength of c-Met effect on g , we can obtain a shift towards the single-well potential with increasing c-Met. This allows us to model the breakdown of cell-cell adhesion and increase in cell-matrix adhesion promoted by c-Met. Additionally, by taking ˜ E as in (5) , where δ 2 indicates strength of c-Met action on ˜ E , we can model the local effect of c-Met on ECM remodeling, since an increased ˜ E increases the driving force of the components independently of whether F is a single-or double-well potential.
The cell velocity, u s , is assumed to satisfy the generalized Darcy's law, which is a constitutive equation that models fluid flow through a porous media ( Lowengrub et al., 2010; Wise et al., 2008 ) ,
where κ reflects combined effects of cell-cell and cell-matrix adhesion, p is the solid pressure generated by cell proliferation, and μ is the chemical potential (3) . We can sum the conservation equations to obtain an equation for velocity ( Wise et al., 2008 ) .
The mass-exchange equations
Src * represents the mass-exchange terms, which incorporate mitosis, differentiation, death, and species conversion. The selfrenewal rate of the CSCs is P 0 , and both the self-renewal and mitosis rates are proportional to the concentration of oxygen and nutrients, represented by a single variable C O . The source terms are as follows:
where mitosis, cell death, and lysis rates are denoted by λ M * , λ A * , and λ L * , respectively, where * indicates cell type. Proliferation is cut off at sufficiently low concentration by G ( φ * ), specifically, we take ( Wise et al., 2008; Youssefpour et al., 2012 ) 
Stem cell self-renewal and division
HGF/c-Met induces cellular proliferation via multiple signaling cascades, including Ras/Raf, PI3K/Akt, NF-κB, and Wnt/ β-catenin ( Birchmeier et al., 2003; Li et al., 2015; Muller et al., 2002; Organ and Tsao, 2011; Trusolino et al., 2010 ) . Moreover, HGF/c-Met has been implicated in CSC development and maintenance in colon cancer , glioblastoma ( Joo et al., 2012; Li et al., 2011 ) and head and neck squamous cell carcinoma (HNSCC) ( Lim et al., 2014 ) . For example, Vermeulen et al. (2010) showed that HGF-induced β-catenin nuclear localization and activation of canonical Wnt signal was associated with increased cellular clonogenicity in primary colon cancer spheroid cultures, implicating the cascade in promoting the CSC phenotype. Similarly, Lim et al. (2014) have shown that in HNSCC HGF/c-Met promoted HNCSCC CSC marker expression and cell sphere-forming capacity. When c-Met was knocked down, the cells showed increased radiosensitivity and decreased ability to form tumors in a mouse xenograft model. HGF has also been shown to have an effect on reducing cell death rates ( Xiao et al., 2001 ).
TGF β is a potent growth inhibitor ( Huang and Huang, 2005 ) and differentiation promoter ( Watabe and Miyazono, 2009 ) for many cell types and early-stage tumors. We model the effect of c-Met and TGF β on stem cell self-renewal and proliferation below.
To lower the parameter burden, we maintain a low, and constant, apoptotic rate in the Src * equations that is not dependent on the growth factors. We take
where C TGF β is the concentration of TGF β, and P min, max and λ MSC min,max are the minimum and maximum rates of self-renewal and CSC division rates, respectively. The strength of the c-Met effect on P 0 and λ MSC is represented by ξ 0 and ξ 1 , respectively, while the strength of the inhibitory TGF β action on P 0 and λ MSC is represented by ψ 0 and ψ 1 , respectively.
Chemical species 2.5.1. Oxygen / nutrients
The combined effect of oxygen and nutrients is denoted as O . Uptake is assumed to be negligible in the host in comparison to the tumor species, and diffusion rapid in comparison to the rate of cell proliferation ( Wise et al., 2008; Youssefpour et al., 2012 ) . Hence, the corresponding concentration C O can be modeled using a quasi-steady state equation,
where ν UOCSC , ν UOTC are the uptake rates by the CSCs and TCs, respectively, and D O is the diffusion coefficient. The rate of O entering the microenvironment is modeled by ν PO , and the concentration of O in the medium sufficiently far from the tumor is given by C AO , which is also taken to be the boundary condition on ∞ , C O = C AO . The host domain is approximated by Q ( c ), an interpolating function from the tumor ( Q = 0 ) to the host ( Q = 1 ), and is taken to be ( Wise et al., 2008 ) Q
where c = 1 − φ T .
TGF β
A diffusible differentiation promoter, produced by the terminal cells, is modeled by the variable TGF β, which represents the TGF β superfamily ( Lombardo et al., 2011; Moses and Serra, 1996 ) . Although in later stages of cancer TGF β may be produced by other cells (namely stroma and immune), we do not model that here since this progression coincides with inactivation of certain TGF β downstream signaling components and results in a phenotypically distinct role of TGF β from its tumor-suppressing effects ( Massagué, 2008 ) . We model the loss of responsiveness to TGF β in Section 3.3 and discuss approaches to modeling the 'TGF β paradox' (i.e. its tumor-promoting actions) in Section 4 .
Rapid diffusion is assumed for TGF β due to the long-range action of some of its family members, such as Activin ( Jones et al., 1996 ) , which is directly involved in regulating epithelial tumorigenesis ( Le Bras et al., 2014 ) , or BMP4, which can have an effective long-range gradient due to long-range diffusion of its inhibitors ( Dale and Wardle, 1999; Jones and Smith, 1998 ) . Hence, we use a quasi-steady reaction-diffusion equation for C TGF β ,
where ν UTGF β is the uptake rate by CSCs, ν DTGF β is the decay rate, ν PTGF β is the production rate by TCs, and D TGF β is the TGF β diffusion coefficient. The boundary condition for C TGF β is taken to be Dirichlet ( C T GF β = 0 ) on ∞ .
c-Met and c-Met inhibitors
A generalized Geirer-Meinhardt-Turing system is used to model the interaction of the activator c-Met and its downstream products with their inhibitors ( Gierer and Meinhardt, 1972; Turing, 1952 ) . Such a system, with Wnt/Dkk as the activator/inhibitor pair has been suggested in hair follicle development ( Sick et al., 2006 ) , crypt generation ( Zhang et al., 2012 ) , and tumor development ( Youssefpour et al., 2012 ) . The large number of cross-activating downstream signaling components of c-Met, some of which include positive feedback loops amongst themselves ( Syed et al., 2011; Verma et al., 2015 ) , motivate a nonlinear c-Met activation term. Inhibitors of c-Met and the downstream effectors activated by induced c-Met include the autocrine-acting c-CBL ( Petrelli et al., 2002 ) , paracrine-acting Delta ( Stella et al., 2005 ) , and the secreted factor Dkk. Since c-Met products are autocrine or paracrine effectors, we take c-Met products to have a short-range, and c-Met inhibitors a long-range, diffusion coefficient. The functional correlation between cancer stem cells and enhanced c-Met activity has been discussed in Section 2.4 , hence we model c-Met and c-Met inhibitor production to be limited primarily to CSCs. We also include low-level background production of c-Met by all viable tumor cell types. Since HGF activates c-Met products and induces cMet production, we model the effect of HGF on c-Met by its positive effect on the production rate of c-Met. Finally, production is made dependent on nutrient ( O ) levels (in this model, we do not consider hypoxia-dependent c-Met upregulation ( Trusolino et al., 2010 ) ). We take proteins, ν PM , is taken to be the sum of ν 0 , the auto-activation rate of M , and λ 1 HGF C HGF .
We note that we have two HGF-dependent actions on c-Met production, with respective strengths λ 1 HGF and λ 2 HGF , due to the multi-modality of HGF action on c-Met and its downstream effectors. In order to better understand how each HGF-dependent action on c-Met affects c-Met product levels and tumor phenotype, we developed a reduced, homogenous model of the system and performed a Turing analysis on it in Appendix A . We assume no flux, homogeneous Neumann, boundary conditions for c-Met and c-Met inhibitor chemical fields, hence we take
HGF and stroma-acting growth factors (SGF)
Cancer cells secrete growth factors and cytokines such as TNF α, bFGF, and PDGF, which induce upregulation of HGF production in stroma-resident fibroblast cells ( De Luca et al., 2010; Gohda et al., 1994; Matsumoto and Nakamura, 2006; Roletto et al., 1996 ) . Because of the lack of definitive data, we cannot currently specify whether the CSCs preferentially release these growth factors, and if increased c-Met signal results in an increased release of these factors, thus we model a positive effect of the growth factors from all viable tumor tissue on HGF production by fibroblasts in the stroma. The fibroblasts are considered to be homogeneously, and densely, distributed within the stroma ( Karagiannis et al., 2012 ) , although there is evidence that ECM remodeling occurs at the tumor-host boundary to allow for tumor spread ( Friedl and Wolf, 2008 ) , we account for this phenomenon not via changing the host phenotype but by making tumor cells more motile (see Section 2.2 ).
Additionally, there is substantial evidence that TGF β is a negative regulator of HGF production in stroma-resident fibroblasts, and thus we include its inhibitory effect in the model ( Gohda et al., 1992; Harrison et al., 20 0 0; Matsumoto and Nakamura, 2006 ) :
where C HGF is the concentration of HGF, ν PHGF and ν DHGF are the respective production and decay rates of HGF, and ζ is a value close to zero added to regularize the equation. The interpolation func- (16) , and D HGF is the diffusion coefficient for HGF. D HGF is taken to be smaller than the diffusion coefficients for the other growth factors due to its high molecular weight ( Nakamura et al., 1989 ). The production rates of SGF by the stem and terminal cell fractions are ν SGF S and ν SGF T , respectively. The decay rate is ν DSGF and D SGF is the diffusion rate of the growth factors. In the main text, we let ν SGF S = ν SGF T , and test the cases where SGF production is significantly higher for the CSC or terminal cell compartment in the Supplementary Material, Section S3.
Nondimensionalized equations
The equations are nondimensionalized following ( Wise et al., 2008; Youssefpour et al., 2012 ) ( Frieboes et al., 2006 ) . The nondimensionalization procedure and parameters are described in Supplementary Material, Section S1 and Section 2.7, respectively. Below we show the equations that change after nondimensionalization, where the others are identical with the dimensional forms, except that variables and parameters are redefined, as explained in the Supplementary Material Section S1 and Section 2.7.
The nondimensionalized equations for O and TGF β, respectively,
The nondimensionalized equations for c-Met and c-Met inhibitors are
Nondimensionalized model parameters
The nondimensional parameter values used in the model are presented in Tables 1 and 2 , for brevity, c-Met is shortened to M and c-Met inhibitors to MI . Since this model is an extension of the Youssefpour et al. (2012) model, with earlier versions published in Konstorum et al. (2013a ) ; 2013b ), a majority are derived from these references, as identified by ( * ) for Youssefpour et al. (2012) and ( * * ) for Konstorum et al. (2013b ) , in the References column of Tables 1 and 2 . Choices of other parameters are discussed in the main text. The reader is referred to the part of the text that address the specific parameter under the References column of Tables 1 and 2 .
Results
An adaptive finite difference nonlinear multigrid method ( Wise et al., 2011; 2008; Youssefpour et al., 2012 ) is used to solve the governing equations efficiently on a computational domain of [ −20 , 20] 2 . We solve for φ T = φ CSC + φ T C + φ DC , then we can calculate φ T C = φ T − (φ CSC + φ DC ) . To remove the high-order time step constraint incurred by an explicit method, we use an implicit 2nd order accurate time discretization of Crank-Nicholson type, and spatial derivatives are discretized using 2nd order accurate central difference approximations. In regions of large gradients, block structured Cartesian refinement is used to provide enhanced local resolution. For further details, see Wise et al. (2011 ) or Youssefpour et al. (2012 .
We initialize the tumor with an asymmetrical shape and a 45/50/5 homogenous fractional distribution of SCs, TCs, and DCs (respectively). We note that changing the initial fractional distribution of cell compartments does not have a qualitative effect on the simulations. The initialized asymmetrical shape can be visualized in the inset in Fig. 2 (a) , its mathematical formulation is described in the Supplementary Material, Section S2. This initial condition provides a diffuse interface representation of an asymmetrical tumor centered at the origin with maximum radius of √ 3 . Choice of a different asymmetrical initial shape does not influence the results in a qualitative manner.
We take initial conditions for C M and C MI , the concentrations of c-Met and c-Met inhibitor, as identical to those for C W and C WI , the concentrations for Wnt and Wnt inhibitors, respectively, in Youssefpour et al. (2012) in order to maintain continuity with the former model in the sense that we want the control condition to be qualitatively similar to the model presented therein. We elaborate on our choice of initial conditions for C M , C MI , as well as for C SGF and C HGF in the Supplementary Material, Section S2. We note that other initial conditions for c-Met, c-Met inhibitor, HGF, and SGF produce qualitatively similar results. Since C O and C TGF β satisfy quasi-steady diffusion equations, we need not take initial conditions for these fields. 
Tumor progression with varying HGF feedback
We begin by simulating HGF dynamics in a tumor in its early stages, when response to inhibitory growth feedback is relatively strong. We do this by setting the TGF β self-renewal feedback parameter, ψ 0 , to ψ 0 = 1 . In Youssefpour et al. (2012) , the authors showed that a growing tumor with no HGF feedback and ψ 0 = 1 grows slower and is more stable than a tumor with ψ 0 = 0 . 5 . In Section 3.3 , we will show how HGF feedback alters tumor behavior with lowered response to TGF β. We incorporate different strengths of HGF feedback (see below) at time T = 10 (recall T is measured in CSC cell cycles) in the simulation. We do this since we expect a delay between tumor initialization and microenvironmental recruitment, although there is evidence that in certain cases, mutations in microenvironmental components may drive tumorigenesis ( Trimboli et al., 2009 ). In our system we consider the tumor as the initiator of the microenvironment-tumor interaction. We note that we do not observe qualitative differences between the choice of early T at which to start the HGF dynamics and the resulting tumor phenotype. 1 Since the strength of the dynamic relationship between HGF and SGF feedback is unknown, we simulate growth of the tumor in four distinct conditions: none, low, intermediate (int), and high HGF feedback. To change the strength of feedback, we focus on three parameters found in Eqs. (23) and (24) , ν PHGF , ν SGF S , and ν SGF T . The strength of SGF action on HGF is represented by ν PHGF , and ν SGF S,T are the respective production rates of SGF by the stem and terminal tissue fractions. For low (respectively, int, high) HGF, we set ν PHGF = ν SGF S = ν SGF T = 5 (respectively 10 , 15) . With HGF dynamics initiated at T = 10 , the stem cell fractions from the resulting simulations for T = 50 , 100, and 150 are shown in Fig. 2 (a) . The outline of the tumor body is clearly visible in all simulations, and is highlighted in green for the no HGF, T = 50 case. We see that as HGF dynamics increase from none to int, the number of stem cell spots increases, and there is a change to a more asymmetrical morphology. As HGF dynamics further increase to the high mode, the number of spots decreases, but the spot size increases, and there is a large change in the morphology with an increase in invasive fingering and tumor fragmentation ( T = 150 ).
We observe that the rate of increase of total tumor area is positively correlated with increasing HGF strength ( Fig. 2 (b)(i) ), namics are incorporated at T ≥ 2. Since we hypothesize that a time delay does occur between tumor initiation and formation of the HGF feedback loop, we present results of simulations when the HGF dynamic is initialized at T ≥ 2. whereas the different cell fractions remain similar over all HGF strengths ( Fig. 2 (b)(ii) ). Indeed, it has been observed that cancer stem cells constitute a stable fraction of the tumor population ( Dalerba et al., 2007 ) . In order to measure the changes in morphology induced by HGF dynamics, we consider the shape factor, SF , for an object, which is calculated by
where P and A are the object perimeter and area, respectively. The shape factor for a circle is SF = 1 , and increases as the shape of the object deviates from a circle. The shape factor tends to increase over time in all cases, but increases more drastically as HGF dynamics increase ( Fig. 2 (b)(iii) ), supporting the experimental results that HGF can induce branching and invasive morphology in exposed tissues and tumors, respectively ( Brinkmann et al., 1995; Ikari et al., 2003; Wong et al., 20 0 0 ) . We fix T = 100 in order to more closely observe other variables associated with the simulations, namely concentrations of c-Met, HGF, and SGF ( Fig. 3 (a) ) and total tumor, terminal cell, and dead cell fractions ( Fig. 3 (b) ). c-Met levels in the spots increase with increasing HGF dynamics, and there is an increase in HGF concentration at the tumor-host boundary and SGF concentration within the tumor ( Fig. 3 (a) ). A large fraction of all the cases contain terminal cells, with a smaller co-localized percentage of dead cells, and with both cell types concentrated outside of the areas with stem cell spots ( Fig. 3 (b) ).
HGF, cell scatter, and pattern formation
In order to better understand how HGF dynamics influence spot formation, we examine the early and late-time dynamics of the simulations with and without c-Met-induced cell scatter (the latter case is simulated by setting δ 1 , 2 = 0 in Eqs. (5) and (6) ). For brevity, we call the case with δ 1 , 2 = 0 , 'ScOff', and the case with δ 1 , 2 = 0 . 02 , 'ScOn'. The values for δ 1, 2 were chosen to simulate a moderate, but observable effect, of HGF on cell-cell and cell-ECM interactions. We observe that c-Met-induced cell scatter results in loss of stem cell spots and an increase in invasive fingering ( Fig. 4 (a) ). We can quantify these effects by measuring the shape factor ( SF , Eq. (32) ) and the stem scatter fraction ( SSF ) of the ScOn and ScOff simulations during the simulation runtime. We calculate the SSF by first measuring the concentration of stem cells in the host tissue, which is taken to be the area of stem cells in the host region normalized to the area of stem cells in the entire domain,
We find SSF and SF are increased for the ScOn compared to the ScOff case ( Fig. 4 ) . This increase in SSF is due to the increased cell scatter, whereas the increase in SF is due to the increased heterogeneity of cell types and behavior at the tumor-host boundary.
Pattern formation is also impacted by the respective strengths of λ 1 , 2 HGF in Eqs. (18) , (20) , and (21) . In Fig. 5 , we observe that if λ 1 HGF = 0 , then as λ 2 HGF increases, we eventually see a continuous strip of stem cells at the tumor host boundary. Alternatively, setting λ 2 HGF = 0 and increasing λ 1 HGF does not result in the increase in spot number, but each spot is bigger, has higher c-Met and c-Met inhibitor concentrations, and gives rise to larger tumor fingers.
To obtain an analytical understanding of the effect of HGF action with respect to these two parameters, we performed a Turing Analysis on a reduced system of two equations modeling a nonlinear reaction-diffusion system with a forcing term ( Appendix A ). In the reduced system (A.1) , we find that an increase in the term ν a , which is linearly proportional to λ 1 HGF C HGF , results in increased steady state ā and b , which correspond to C M and C MI , respectively, in the original system, and no effect on the critical wavenumber, q min , ( Eq. (A.6) ) or maximum eigenvalues ( Eq. (A.8) ) of A q , as defined in Eq. (A.7) . This system corresponds to the simulations with (λ 1 HGF , λ 2 HGF ) = (x, 0) , where x is positive, as shown in the bottom row of Fig. 5 , where we indeed see no change in the number of stem cell spots, but do see an increase in both C M and C MI . Alternatively, the Turing Analysis on system (A.9) shows that increasing the term E a , which corresponds to λ 2 HGF C HGF in the original system, leads to a decrease in the critical wavenumber q min and maximal eigenvalues of A q ( Fig. A.1 ) . We would expect such a system to eventually become more stable with increasing E a , especially at low ν a , since the decrease in maximal eigenvalues indicates that the growth rates of the perturbations will decrease with increasing E a . Although q min is decreasing, which signals that we may find more unstable wave numbers, a very low perturbation growth rate suggests that pattern formation will not occur. In the original system, when we take (λ 1 HGF , λ 2 HGF ) = (0 , x ) , with x positive, we indeed see a uniform band of stem cells forming when λ 2 HGF is large enough ( Fig. 5 ) .
Effect of negative feedback on tumor growth
A common characteristic of tumors that progress from preneoplastic lesions to neoplasms is that they lose the ability to respond to negative growth feedback signals ( Hanahan and Weinberg, 2011 ) . For example, in colorectal cancer, resistance to TGF β by mutation of a cognate receptor is associated with progression from adenoma to malignant carcinoma ( Grady et al., 1998 ) .
The TGF β pathway can also be inactivated by a mutation of the TGF β receptor TGF βR2 or by inactivation of downstream signaling components SMAD2, SMAD3, or SMAD4 ( Markowitz and Bertagnolli, 2009 ).
Loss of response to members of the TGF β family is correlated with poorer prognosis in a clinical setting ( Pickup et al., 2013 ) . Therefore, to model the effect of HGF dynamics in a tumor that has progressed beyond the initial stages, we reduce the strength of TGF β feedback on stem cell self-renewal from ψ 0 = 1 . 0 to ψ 0 = 0 . 5 . When compared to the case with ψ 0 = 1 . 0 , the simulation results with reduced response to negative feedback have a greater total area and shape factor, indicating the enhanced invasive potential of such tumors ( Fig. 6 ) .
Therapy
Therapies targeting various aspects of the HGF/c-Met axis, including antibodies against HGF and c-Met, HGF-competitive analogs, tyrosine kinase inhibitors (TKIs) targeting c-Met, and downstream pathway inhibitors are currently in development ( Blumenschein et al., 2012; Knudsen and Vande Woude, 2008 ) . Over 20 drugs are currently in Phase I-III clinical trials ( Cecchi et al., 2012 ) , indicating strong interest by the biomedical community in translating the accumulated knowledge of the HGF/c-Met axis into cancer therapeutics. We model targeted therapy by changing ν 0 , the strength of c-Met auto-activation, and λ 1 , 2 HGF , the strength of HGF-induced c-Met activation, in Eqs. (20) and (21) . Lowering λ 1 HGF and λ 2 HGF models drugs that act by inhibiting HGF (class T 1 ), while lowering ν 0 represents drugs that specifically disrupt c-Met auto-catalysis. Drugs that inhibit cMet or its downstream effectors lower both auto-catalysis rates and the ability of HGF to upregulate c-Met products (class T 2 ). Therefore, activity of such drugs should be modeled by lowering all three parameters. We model class T 1 and T 2 drugs as follows, at T = 50 we apply either therapy T 1 , which lowers λ 1 HGF and λ 2 HGF from 0.5 to 0.05 or therapy T 2 , which lowers λ 1 HGF and λ 2 HGF to 0.005 and ν 0 from 1.0 to 0.1 ( Fig. 7 ) . We choose these two therapies as they represent two different classes of drugs as described above, and they also represent the two classes of therapy results that were observed when both parameters were systematically lowered for high HGF ( Figure S2) . Therapy is applied until the last time point, T = 150 . We find that therapy class T 1 results in decreased total area and shape factor, but it is the T 2 class that results in a shape factor close to 1, indicating that the invasive morphology has been significantly reduced along with total tumor size. It has been shown that very strong inhibition of c-Met phosphorylation ( > 90%) is required for significant inhibition of tumor growth ( > 50%) in a tumor xenograft mouse model ( Yamazaki et al., 2008 ) , which is consistent with our simulation results. Additionally, we find that when therapy is terminated prematurely, the tumor grows back rapidly ( Figure S2 ), indicating that ultimate tumor eradication requires combination therapy and/or surgical resection alongside anti-HGF/c-Met drugs. We note that in Yamazaki et al. (2008) , mice were euthanized maximally 24 h after the last therapy dose, which lasted between 9-11 days, hence it is not known what the tumor behavior would have been for a longer period after therapy cessation.
Discussion
By incorporating tumor-produced SGF and the HGF/c-Met axis into a multispecies model of tumor growth, we have shown that establishment of a dynamic interaction between the tumor and its microenvironment results in increased tumor growth and morphological instability, the latter due in part to increased cell-species heterogeneity at the tumor-host boundary. Indeed, such a phenomenon has been investigated by Cristini et al. (2005) . Using both experimental and simulation results, ( Cristini et al., 2005 ) showed that spatially heterogeneous cell proliferation, alongside disruption of cell-cell adhesion, results in invasive fingering and migration of cell clusters. In their model, the heterogeneity occurred due to heterogeneous distribution of oxygen, nutrients, and pH levels caused by atypical tumor vasculature and other disruptions to diffusion in the tumor. Similarly, in a hybrid cellular automata and PDE tumor growth model, ( Sottoriva et al., 2010 ) showed that a tumor that has a 100% CSC fraction yields a sphere-like morphology whereas tumors with low CSC fractions (in this model, CSCs differ from differentiated cells, DCs, in that CSCs have unlimited replicative potential, can migrate and mutate unlike the DCs), show invasive fingering with highly irregular shape. In our model, the heterogeneity occurs due to formation of stem cell spots at the tumor-host boundary via a Turing mechanism of c-Met and c-Met inhibitors. This heterogeneity is exacerbated by the presence of HGF-SGF signaling cross-talk since the effect of HGF on cell scatter results in a more irregular spot distribution at the tumor-host boundary, and the effect of HGF on proliferation/self-renewal increases the size of the remaining spots. Thus, when the effect of HGF on cell scatter is removed from the model, the tumor becomes more stable due to a more uniform distribution of stem cell spots at the tumorhost boundary, even though there are more such spots than in the original model ( Fig. 4 ) . ( Cristini et al., 2005 ) propose that suppression of morphologic instability via homogenization of cell proliferation and increase in cell-cell adhesion will result in a more compact, noninvasive tumor morphology. Our therapy results support their conclusions: when we block the HGF/c-Met axis sufficiently enough to reduce the highly proliferative spot size, the tumor does not only grow more slowly, but it grows in a more compact manner ( Fig. 7 ) .
We find that invasive behavior is further increased if the tumor lowers responsiveness to tumor-derived pro-differentiation signals, which is a traditional hallmark of neoplastic development ( Hanahan and Weinberg, 20 0 0 ). We have not addressed a portion of the pleiotropic effects of TGF β that constitute the 'TGF β paradox'. Namely, our model does not consider that in certain cases, TGF β can increase cellular motility, as well as hasten the Epithelial-to-Mesenchymal Transition (EMT) of tumorigenic epithelial cells ( Pickup et al., 2013 ) . Moreover, it has been found that in advanced cancers, immune components and fibroblasts can produce TGF β, which has tumor-promoting effects ( Massagué, 2008 ) . In this study, we only model the anti-proliferative effects of TGF β, with its production localized to terminal cells. Incorporation of the tumor-promoting action of TGF β may be best done using a specific cancer model and data, since such effects show greater diversity among different cancers than the other growth factors modeled in this study.
By modeling anti-HGF and anti-c-Met therapy, we show how disruption of the HGF/c-Met cascade can lower tumor invasiveness and growth, thereby providing theoretical evidence that targeting tumor-microenvironment dynamics is a promising avenue for therapeutic development. An important consideration in clinical development of anti-HGF/c-Met therapies is patient selection and stratification. Studies on efficacy of HGF/c-Met targeted therapies have consistently shown that patients with high c-Met expression levels respond best to these therapies ( Graveel et al., 2013 ) , indicating that patient pre-selection based on tumor biomarkers of HGF/c-Met axis activation can improve therapy outcomes ( Blumenschein et al., 2012 ). As our model assumes c-Met as a main driver in stem cell self-renewal and division rate, it is most directly applicable to patients with high c-Met activity.
Many of our assumptions and results are based upon quantification of specific features of the tumor and its microenvironment, including the spatially-distributed stem cell fraction of the tumor, and chemical diffusion, uptake, and activity coefficients. In order to better align our model with experimental observations, it is necessary to use an experimental system that is capable of recapitulating and capturing some of the complexities of the tumor microenvironment. In their review of emerging technologies in this field, ( Guldner and Zhang, 2015 ) noted that new technology is nec-essary to explore the tumor microenvironment that incorporates spatial and temporal dynamics of tumor-microenvironmental interactions, and can measure cell-type specific behavior. They discuss emerging technologies that can aide in this goal, including deep tissue optical sectioning, intravital microscopy (IVM, the imaging of live animal tissue), and in situ cell-type specific genetic isolation. For example, Tanaka et al. (2012) used IVM in a liver metastatic xenograft system where RFP-labeled human colorectal cells were injected into GFP-expressing nude mice to obtain a time-series of the phenotypic changes in tumor and host during liver metastasis and with and without chemotherapy. In addition, development of sophisticated 3D-culture systems where protein and drug diffusion and uptake rates can be measured via techniques such as FRAP or FLIM-FRET, which are already in use ( Conway et al., 2014; Talukdar and Kundu, 2012 ) . Therefore, it is possible to construct an appropriate experimental system to test the hypotheses generated by our model regarding quantifiable tumor behavior with an activated HGF/c-Met axis, such as increased invasiveness and formation of areas with high stem-cell concentration at the tumor-host boundary.
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In order to simplify stability analysis of the system, we take Importantly, the eigenvalues also do not depend on ν a .
We can thus conclude that in an activator-inhibitor reaction of this type, the steady state of a will be directly proportional to ν a , but pattern formation will not be influenced.
A2. Simplified nonlinear activator-inhibitor model with an additional forcing term
We now introduce the additional term E a to system (A.1) to represent non-trivial λ 2 HGF as follows: , there is one real solution to the system ( f 1 , f 2 ) = (0 , 0) , but it is unwieldy analytically. Therefore, we find ( ā , b ) , A, q min , and eiqenvalues of A q for specific values of ν a and E a . We take ν a = { 5 , 10 , 15 , 20 } and E a = { 5 , 10 , 15 , 20 } . We also take d a = d b = ν b = 1 . We find the real-valued ( ā , b ) using the 'solve' function in Matlab for ( f 1 , f 2 ) = (0 , 0) .
In Fig. A.1 (a,b) , we observe that while increasing ν a leads to an increase in both ā and b , the effect of E a on ā and b is much less pronounced.
As before, we find A = (a i j ) , the Jacobian of the system ( f 1 ( a, b ) ( Fig. A.1 c) . We note that q min decreases as E a increases, and this decrease is stronger at lower values of ν a . Moreover, taking A q as in Eq. (A.7) , with q = q min , the maximum eigenvalue decreases with increasing E a and decreasing ν a ( Fig. A.1 (d) ).
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